{"SPADE_UN_30236": {"Sequence Information": {"Peptide Name": "Melittin (21-25) + Protamine (21-32), Mel-4", "Sequence": "KNKRKRRRRRRGGRRRR", "Sequence Length": 17, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "P69015", "uniprotUrl": "http://www.uniprot.org/uniprot/P69015", "description": "The amino acid sequence of the current peptide coincides with the amino acid sequence of the UniProt entry."}, {"uniprotId": "P01501", "uniprotUrl": "http://www.uniprot.org/uniprot/P01501", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}], "Literature": [{"Title": "Antimicrobial activity of four cationic peptides immobilised to poly-hydroxyethylmethacrylate.", "Pubmed ID": "26934297", "Reference": "Biofouling. 2016;32:429-438", "Author": "Dutta D, Kumar N, Willcox MD", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/26934297"}, {"Title": "Activity of a melimine derived peptide Mel4 against Stenotrophomonas, Delftia, Elizabethkingia, Burkholderia and biocompatibility as a contact lens coating.", "Pubmed ID": "28118996", "Reference": "Cont Lens Anterior Eye. 2017;40:175-183", "Author": "Dutta D, Zhao T, Cheah KB, Holmlund L, Willcox MDP", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/28118996"}, {"Title": "Comparative mode of action of the antimicrobial peptide melimine and its derivative Mel4 against Pseudomonas aeruginosa.", "Pubmed ID": "31068610", "Reference": "Sci Rep. 2019;9:7063", "Author": "Yasir M, Dutta D, Willcox MDP", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/31068610"}, {"Title": "Mode of action of the antimicrobial peptide Mel4 is independent of Staphylococcus aureus cell membrane permeability.", "Pubmed ID": "31356627", "Reference": "PLoS One. 2019;14:e0215703", "Author": "Yasir M, Dutta D, Willcox MDP", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/31356627"}, {"Title": "A Pilot Study of the Synergy between Two Antimicrobial Peptides and Two Common Antibiotics.", "Pubmed ID": "31075940", "Reference": "Antibiotics (Basel). 2019;8:60", "Author": "Kampshoff F, Willcox MDP, Dutta D", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/31075940"}], "Mass": 2348.78, "PI": 12.0, "Net Charge": 14, "Hydrophobicity": -3.85, "Frequent Amino Acids": "RKG", "Absent Amino Acids": "ACDEFHILMOPQSTUVWY", "Basic Residues": 14, "Acidic Residues": 0, "Hydrophobic Residues": 0, "Polar Residues": 17, "Positive Residues": 14, "Negative Residues": 0, "SPADE ID": "SPADE_UN_30236", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_11384", "Similarity": 1.0, "Sequence": "TLISWIKNKRKQRPRVSRRRRRRGGRRRR"}, {"SPADE_ID": "SPADE_UN_30236", "Similarity": 1.0, "Sequence": "KNKRKRRRRRRGGRRRR"}, {"SPADE_ID": "SPADE_N_04917", "Similarity": 1.0, "Sequence": "RKRRR"}], "Hemolytic Activity": "Horse erythrocytes:0% Hemolysis=16.50 µM,Horse erythrocytes:5% Hemolysis=1703.68 µM", "Target Organism": "Pseudomonas aeruginosa 6294(MIC=250µg/ml),Staphylococcus aureus 31(MIC=125µg/ml),Stenotrophomonas maltophilia(MIC=31.2µg/ml),Elizabethkingia meningoseptica(MIC=500µg/ml),Delftia acidovorans(MIC=1000µg/ml),Burkholderia cepacia(MIC=1000µg/ml),Pseudomonas aeruginosa 6294(MBC=250µg/ml),Pseudomonas aeruginosa 6206(MIC=62.5µg/ml),Pseudomonas aeruginosa 6206(MBC=125µg/ml),Pseudomonas aeruginosa PAER1(MIC=250µg/ml),Pseudomonas aeruginosa PAER1(MBC=500µg/ml),Pseudomonas aeruginosa ATCC 19660(MIC=62.5µg/ml),Pseudomonas aeruginosa ATCC 19660(MBC=62.5µg/ml),Staphylococcus aureus 31(MIC=106.48µM),Staphylococcus aureus 31(MBC=212.96µM),Staphylococcus aureus 38(MIC=106.48µM),Staphylococcus aureus 38(MBC=212.96µM),Staphylococcus aureus ATCC 6538(MIC=53.24µM),Staphylococcus aureus ATCC 6538(MBC=53.24µM)"}}}